Beta-glucans (saccharomyces cereviseae) reduce glucose levels and attenuate alveolar bone loss in diabetic rats with periodontal disease
Viviam de Oliveira Silva, Raquel Vieira Lobato, Eric Francelino Andrade, Cristina Gomes de Macedo, Juliana Trindade Clemente Napimoga, Marcelo Henrique Napimoga, Michel Reis Messora, Ramiro Mendonca Murata, Luciano José Pereira
ARTIGO
Inglês
The objective of this study was to assess the effects of oral ingestion of beta-glucans isolated from Saccharomyces cereviseae on the metabolic profile, expression of gingival inflammatory markers and amount of alveolar bone loss in diabetic rats with periodontal disease. Diabetes mellitus was...
Ver mais
The objective of this study was to assess the effects of oral ingestion of beta-glucans isolated from Saccharomyces cereviseae on the metabolic profile, expression of gingival inflammatory markers and amount of alveolar bone loss in diabetic rats with periodontal disease. Diabetes mellitus was induced in 48 Wistar rats by intraperitoneal injection of streptozotocin (80 mg/kg). After confirming the diabetes diagnosis, the animals were treated with beta-glucans (by gavage) for 28 days. On the 14th day of this period, periodontal disease was induced using a ligature protocol. beta-glucans reduced the amount of alveolar bone loss in animals with periodontal disease in both the diabetic and non-diabetic groups (p < 0.05). beta-glucans reduced blood glucose, cholesterol and triacylglycerol levels in diabetic animals, both with and without periodontal disease (p < 0.05). Furthermore, treatment with beta-glucans reduced the expression of cyclooxygenase-2 and receptor activator of nuclear factor kappa-B ligand and increased osteoprotegerin expression in animals with diabetes and periodontal disease (p < 0.05). It was concluded that treatment with beta-glucans has beneficial metabolic and periodontal effects in diabetic rats with periodontal disease
Ver menos
CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTÍFICO E TECNOLÓGICO - CNPQ
481125/2013-2; 302424/2011-3
COORDENAÇÃO DE APERFEIÇOAMENTO DE PESSOAL DE NÍVEL SUPERIOR - CAPES
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE MINAS GERAIS - FAPEMIG
APQ01692-12; PPM00268/14; BPD00312-14
aberto
Beta-glucans (saccharomyces cereviseae) reduce glucose levels and attenuate alveolar bone loss in diabetic rats with periodontal disease
Viviam de Oliveira Silva, Raquel Vieira Lobato, Eric Francelino Andrade, Cristina Gomes de Macedo, Juliana Trindade Clemente Napimoga, Marcelo Henrique Napimoga, Michel Reis Messora, Ramiro Mendonca Murata, Luciano José Pereira
Beta-glucans (saccharomyces cereviseae) reduce glucose levels and attenuate alveolar bone loss in diabetic rats with periodontal disease
Viviam de Oliveira Silva, Raquel Vieira Lobato, Eric Francelino Andrade, Cristina Gomes de Macedo, Juliana Trindade Clemente Napimoga, Marcelo Henrique Napimoga, Michel Reis Messora, Ramiro Mendonca Murata, Luciano José Pereira
Fontes
|
PLoS one Vol. 10, no. 8 (Aug., 2015), p. e0134742 |